NSE - Free Realtime Quote INR

Ipca Laboratories Limited (IPCALAB.NS)

1,316.90 -12.05 (-0.91%)
As of 12:43 PM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
71,461,900.00
62,068,500.00
57,664,600.00
53,660,000.00
Cost of Revenue
25,820,400.00
24,075,100.00
21,059,700.00
18,017,600.00
Gross Profit
45,641,500.00
37,993,400.00
36,604,900.00
35,642,400.00
Operating Expense
37,119,900.00
30,945,800.00
25,978,300.00
22,462,200.00
Operating Income
8,521,600.00
7,047,600.00
10,626,600.00
13,180,200.00
Net Non Operating Interest Income Expense
-506,500.00
311,600.00
229,700.00
246,800.00
Pretax Income
8,955,100.00
7,452,900.00
11,357,200.00
13,889,800.00
Tax Provision
2,881,400.00
2,533,600.00
2,247,700.00
2,401,400.00
Net Income Common Stockholders
5,642,800.00
4,713,200.00
8,840,800.00
11,400,100.00
Diluted NI Available to Com Stockholders
5,642,800.00
4,713,200.00
8,840,800.00
11,400,100.00
Basic EPS
22.25
18.58
34.85
45.01
Diluted EPS
22.25
18.58
34.85
45.01
Basic Average Shares
253,642.60
253,704.22
253,704.22
253,279.56
Diluted Average Shares
253,642.60
253,704.22
253,704.22
253,279.56
Rent Expense Supplemental
--
164,100.00
154,700.00
139,900.00
Total Expenses
62,940,300.00
55,020,900.00
47,038,000.00
40,479,800.00
Net Income from Continuing & Discontinued Operation
5,642,800.00
4,713,200.00
8,840,800.00
11,400,100.00
Normalized Income
5,007,696.80
4,544,028.73
8,810,882.03
11,478,675.50
Interest Income
--
793,500.00
341,700.00
369,500.00
Interest Expense
1,269,000.00
450,900.00
72,400.00
86,100.00
Net Interest Income
-506,500.00
311,600.00
229,700.00
246,800.00
EBIT
10,224,100.00
7,903,800.00
11,429,600.00
13,975,900.00
EBITDA
13,510,600.00
10,519,400.00
13,753,800.00
16,067,600.00
Reconciled Cost of Revenue
25,820,400.00
24,075,100.00
21,059,700.00
18,017,600.00
Reconciled Depreciation
3,286,500.00
2,615,600.00
2,324,200.00
2,091,700.00
Net Income from Continuing Operation Net Minority Interest
5,642,800.00
4,713,200.00
8,840,800.00
11,400,100.00
Total Unusual Items Excluding Goodwill
936,400.00
256,300.00
37,300.00
-95,000.00
Total Unusual Items
936,400.00
256,300.00
37,300.00
-95,000.00
Normalized EBITDA
12,574,200.00
10,263,100.00
13,716,500.00
16,162,600.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
301,296.80
87,128.73
7,382.03
-16,424.50
3/31/2021 - 1/1/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GRANULES.NS Granules India Limited
416.15
+0.43%
 
LAURUSLABS.NS Laurus Labs Limited
432.50
+0.57%
 
AUROPHARMA.NS Aurobindo Pharma Limited
1,083.90
+0.71%
 
LUPIN.NS Lupin Limited
1,592.65
-0.69%
 
ZYDUSLIFE.NS Zydus Lifesciences Limited
954.70
-0.52%
 
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,029.00
-0.99%
 
BAJAJHCARE.BO Bajaj HealthCare Limited
319.00
+0.49%
 
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,489.70
-3.27%
 
VENUSREM.NS Venus Remedies Limited
332.80
-0.21%
 
ORCHPHARMA.NS Orchid Pharma Limited
1,060.00
+0.62%